Company intelligence / Profile preview

More Diagnostics

United States

Ownership: Private
Development stage: Other

Overview

More Diagnostics provides ISO-certified, stable, high-quality in vitro diagnostic controls, mainly for immunosuppressant drug monitoring and cardiac assays. Their products are liquid human preparations, universally compatible with lab test systems—widely used for clinical accuracy and regulatory compliance

Therapeutic areas: CardiovascularImmunology
Modalities: Device (Diagnostic controls)
Industry: Protein Biomarker Diagnostics

Partnerships

Major IVD manufacturers use their matrices as OEM partners

Beyond the preview

Go deeper on More Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on More Diagnostics.

Explore the full profile